- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
Ishwaria Mohan Subbiah on Older Patients Enrolled in Clinical Trials
Ishwaria Mohan Subbiah, a physician at the MD Anderson Cancer Center, discusses elderly people on clinical trials.
Ishwaria Mohan Subbiah, a physician at the MD Anderson Cancer Center, discusses elderly people on clinical trials.
After observing 1,400 patients on phase 1 clinical trials at MD Anderson Cancer, Subbiah realized that patients over the age of 65 had similarly positive clinical outcomes as younger cohorts. However, she also found that while these older patients make up about half of the new cancer cases each year in the United States, they make up a much smaller proportion of patients enrolled in clinical trials.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More
